Navigation Links
STALLERGENES : Strong Business Growth: +17% and Earnings Per Share up 30%
Date:8/28/2007

PARIS, August 28 /PRNewswire-FirstCall/ -- The Board of Directors, meeting on 28 August 2007, under the chairmanship of Albert Saporta approved the consolidated financial statements at 30 June 2007:

(EUR millions) 2007 % of 2006 % of % change

HY1 sales HY1 sales 2007/2006

Sales 74.8 100.0 64.2 100.0 17

Cost of sales (16.9) (22.5) (14.6) (22.7) 16

Gross profit 57.9 77.5 49.6 77.3 17

General, (31.3) (41.9) (28.0) (43.6) 12

administrative and

selling expenses

Gross operating profit 26.6 35.6 21.6 33.7 23

before R&D

R&D (11.2) (15.0) (9.4) (14.6) 19

Operating profit 15.4 20.6 12.2 19.1 26

Net profit (Group 10.1 13.6 7.7 12.0 32

share)

Net earnings per share 0.76 0.59 30

(diluted, in EUR)

Net borrowings 9.3 (16%) 13.3 (29%) (30)

(gearing)

2007 1st half-year registered a marked improvement in operating profitability

Operating profit (up 26%) fully benefited from the sharp growth in sublingual route sales (up 21%), a segment in which Stallergenes consolidated its leadership and strategic positioning. Net profit increased by 32% to EUR 10.1 million. Net borrowings were down 30%.

International roll-out of operations

The 1st half-year represents a major milestone in the Group's international development: incorporation of Stallergènes BV in Holland, active preparation of the ORALAIR(R) Grasses tablet registration in Canada, operational rollout in the East of the European Union (Austria, Slovenia and Romania).

Outlook

The Company remains confident in the registration of ORALAIR Grasses in Germany at the end of 2007 and in the initialisation of the m
'/>"/>

SOURCE Stallergenes
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Lance Armstrong and the future of cancer care
2. Entrepreneurship grant will build strong foundation
3. Corporate control begins with a strong board
4. Midwest colleges strong contenders for NIH funds
5. Fiserv reports stronger earnings and revenues
6. Third Wave reports another loss, stronger sales
7. Is Wisconsins economy stronger, weaker, or just changing?
8. Third coast of biotechnology makes strong showing at VC conference
9. Fiserv Reports Strong Earnings for Third Quarter of 2005
10. UWs Waisman Center seeing strong demand for biomanufacturing facility time
11. Midwest holds strong position in worldwide diagnostics business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... (PRWEB) August 29, 2014 Three ... Energy's 2014 Hydrogen Production R&D Award ... by splitting water using sunlight. , Shared with ... and the University of Nevada, Las Vegas (UNLV), ... developing models of photoelectrochemical solar-hydrogen production and corrosion ...
(Date:8/28/2014)... August 28, 2014 SPIE Fellow Glenn ... and Optical Science and Director of the Center for ... Carolina at Charlotte, and co-founder and Chairman of the ... as the 2015 Vice President of SPIE, the international ... Philip Stahl announced recent election results at the Annual ...
(Date:8/28/2014)... Ind. A new research platform uses ... of tiny structures undergoing stress and heating, ... improve designs for microelectronics and batteries., This ... information about how heating and the surface ... properties. Researchers have discussed the merits of ...
(Date:8/28/2014)... Aug. 28, 2014  Next month, executives from clinical trial ... industry events beginning with Patient-Centered Clinical Trials 2014 , ... Boston , September 4-5. Patient recruitment experts ... Aaron Fleishman will share insights on the benefits of ... of tactics – from media to mobile apps – can ...
Breaking Biology Technology:Livermore Team Awarded for Hydrogen Production Research 2Glenn Boreman, UNC Professor and Plasmonics Co-Founder, Elected to SPIE Presidential Chain 2New analytical technology reveals 'nanomechanical' surface traits 2New analytical technology reveals 'nanomechanical' surface traits 3BBK Worldwide Leads Sessions at Key September Events 2
... on November 2nd and New York on November ... Inc. (Nasdaq:,FVRL), a biopharmaceutical company developing patient-specific, active,immunotherapies ... the,Company will present at three upcoming investor conferences: ... Ghalie, M.D., Chief Medical Officer, will present at ...
... (Nasdaq:,SIAL), a life science company dedicated to providing ... and Oxford,BioMedica (LSE: OXB), a leading gene therapy ... confirming the strength and validity of,intellectual property owned ... field to Sigma-Aldrich. The ruling was part of ...
... to "de-cloak" cancers -, TORONTO, Oct. 25 ... company discovering and developing the next wave of,antibody ... from its Trop-2 and CD59 antibody programs. ARIUS ... at the AACR press,conference today at 9:30 a.m. ...
Cached Biology Technology:Favrille to Present at BIOCOM Investor Conference, Acumen BioFin Rodman & Renshaw Healthcare Conference and CIBC World Markets Healthcare Conference 2Sigma-Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute 2Sigma-Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute 3Arius announces new findings in Trop-2 and CD59 CANCER antibody programs 2Arius announces new findings in Trop-2 and CD59 CANCER antibody programs 3
(Date:9/1/2014)... nucleotidethe basic building block of DNAcould initiate fragile X syndrome, the ... The Journal of Cell Biology . ... gene on the X chromosome called fragile X mental retardation ... 360 men carry a so-called premutation, in which a series of ... is slightly longer than normal. These repeats are prone to even ...
(Date:9/1/2014)... As nocturnal animals, bats are perfectly adapted to a life ... between the reflected echoes to measure distance to obstacles or ... different echo delays. A study carried out by researchers at ... that this map dynamically adapts to external factors. , ... bat flies in too close to an object, the number ...
(Date:8/31/2014)... Scientists at the University of Warwick have discovered that ... , The substance, methylglyoxal - MG, was found ... of bad cholesterol from the body. , Low ... to heart disease, with increased levels of MG being ... kidney problems. , Supported by funding from the ...
Breaking Biology News(10 mins):A nucleotide change could initiate fragile X syndrome 2Zooming in for a safe flight 2Sugar substance 'kills' good HDL cholesterol, new research finds 2
... carried through the atmosphere before settling on the ocean ... new research from the University of Michigan and the ... Earth Science and Technology (SOEST) combines biogeochemistry and direct ... cycle is colliding with ocean fishand the human seafood ...
... members from The University of Texas at Arlington are ... of Texas System Board of Regents for excellence in ... $25,000 cash award and recognize faculty members at UT ... innovation at the undergraduate level. The professors were recognized ...
... Center Researcher Song-Yi Park, PhD, along with her colleagues, ... vegetables may lower the risk of invasive bladder cancer ... part of the Multiethnic Cohort (MEC) Study, established in ... factors, and cancer risk. Park and her fellow researcher,s ...
Cached Biology News:Ocean fish acquire more mercury at depth 2Ocean fish acquire more mercury at depth 3Ocean fish acquire more mercury at depth 49 UT Arlington educators honored for teaching excellence 2
Collected from 8-12 week old sexually mature rats. Pricing: $100/unit for 1 - 10 units...
PlusOne Acrylamide PAGE, 1 kg. Category: Electrophoresis Systems & Standards & Reagents, Electrophoresis Standards and Reagents, Gel Casting Chemicals....
... Kit is one of the most ... of RNA in solution. The ... than absorbance measurements. As little as ... fluorescence microplate readers and fluorometers using ...
... The GenoStat Inducible Expression System provides tightly ... mammalian cells and is capable of repeated ... is mediated by the highly specific interaction ... bipartite nuclear receptor complex. Gene expression levels ...
Biology Products: